Jeito Capital co-leads $65 million Series A financing in EyeBio
Jeito Capital co-leads $65 million Series A financing in EyeBio EyeBio is a newly launched global company developing the next generation of eye disease therapies Founded by two pioneers in ophthalmology drug development to build and advance diversified pipeline of ocular therapies Jeito selects EyeBio as its 8th investment and